Hybrid molecular imaging modalities, such as PET/CT and SPECT/CT, have seen rapid growth in the industry, said Xiaoyi Wang, president and co-founder of Thinking Systems, in this interview with DOTmed News. "To support this growth, and to be able to take advantage of the technologies offered by these modalities, PACS infrastructure will have to be in place so the values provided by these modalities can be extended to the point of patient care," Wang said.

Full Story:

Related Summaries